On February 5th, Dubai time, B&E Bio-Tech held a distributor meeting and new product launch during the Medlab Middle East 2025 exhibition. The event highlighted the introduction of several innovative medical diagnostic devices including the i-check blood gas analyzer, KS-402 fully automatic electrolyte analyzer, G21 glycated hemoglobin analyzer, and Hemax53+FI fully automatic hematology analyzer. Global customers, experts, and partners attended the meetings and launch.
During the sessions, the B&E team emphasized the advantages of their handheld blood gas products: employing advanced dry bio-sensor technology to deliver results in just one minute, offering ease of use, stable performance, and the convenience of using test cards without needing to return to room temperature. Attendees showed great interest and provided high praise after experiencing the products, recognizing significant advantages in terms of performance, operation, and cost. Furthermore, attendees engaged in deep discussions with the team on various applications. Their feedback not only praised the product's performance but also offered valuable insights and suggestions for practical clinical applications. This interaction not only enhanced mutual understanding but also laid a solid foundation for future collaborations.
"We are very pleased to showcase our latest achievements on such an important platform as Medlab Middle East," said a representative of B&E. "Through continuous technological innovation and optimization, we are committed to providing more efficient and accurate medical diagnostic equipment for our global customers. In the future, we will continue to increase investment in R&D and actively expand into international markets to help improve global public health standards."
The launch event demonstrated B&E’s product strengths and facilitated exchanges and cooperation with international customers. The company plans to sustainably invest in R&D and innovation to support the advancement of global healthcare. With the growing demand for high-quality diagnostic equipment in the global medical market, this presents new development opportunities for the company. B&E is dedicated to providing premium products and services to patients around the world.
